期刊文献+

术前新辅助放化疗对食管癌原发灶病理形态学及Ki-67表达的影响 被引量:1

Expression of Ki-67 and pathomorphological response after preoperative chemoradiotherapy in patients with esophageal cancer
原文传递
导出
摘要 目的研究术前新辅助放化疗对食管肿瘤病理形态学改变及对食管癌细胞增殖的影响,并探讨二者之间的关系。方法选择40例食管鳞癌初治患者,治疗前经食管镜活检病理确诊,行新辅助放化疗加根治性手术治疗,术后常规进行手术标本病理学检查,免疫组化染色分别检测治疗前活检标本和手术标本Ki-67表达的标记指数。结果放化疗后重度反应者12例(30.0%),中度反应20例(50.0%),轻度反应8例(20.0%)。显著有效率30.0%,总有效率80.0%。放化疗前、后食管鳞癌组织中Ki-67表达的标记指数差异有统计学意义(P<0.01);重、中度放化疗反应组放化疗前、后Ki-67标记指数的差异有统计学意义(P<0.01);轻度反应组放化疗前Ki-67标记指数与放化疗后存在差异,但差异无统计学意义(P>0.05)。结论多数食管癌患者接受新辅助放化疗后仍有肿瘤病灶存在,约20%的患者肿瘤组织退缩不明显。放化疗前后食管鳞癌组织中Ki-67表达的标记指数明显下降,提示放化疗后肿瘤的增殖能力较放化疗前下降。 Objective To investigate the effect of preoperative radiochemotherapy on proliferation and alteration of primary lesion pathology in esophageal carcinoma.Methods 40 patients with esophageal carcinoma enrolled into this study received biopsy by an esophagoscope prior to treatment and then preoperative adjuvant radiochemotherapy and surgical treatment.Expression of the Ki-67 protein in both biopsy and postoperative specimens was detected by immunohistochemical staining technique.Results After surgery,8(20%) patients were detected with tumor regression in a mild degree,20(50%) in a moderate degree,and 12(30%) in a severe degree.The overall response rate was 80%.Expression of Ki-67,as a predictive marker of response to preoperative chemoradiotherapy for esophageal cancers,was significantly correlated with tumor regression.Expression of Ki-67 was significantly decreased in tumors with severe response to preoperative treatment,when compared to those with moderate and mild responses(P〈0.01).Expression of Ki-67 in the slightly shrank group was lower after radiochemotherapy than that before radiochemotherapy,while the difference was not significant(P〉0.05).Conclusion There are still relict tumor cells after radiochemotherapy in most patients with esophageal carcinoma,about 20% of which are detected without significant tumor regression.Expression level of Ki-67 in esophageal carcinoma tissues significantly descends after radiochemotherapy,which may imply proliferation and invasion of the tumor decrease.
出处 《山东大学学报(医学版)》 CAS 北大核心 2011年第7期125-128,131,共5页 Journal of Shandong University:Health Sciences
基金 山东省自然科学基金资助课题(Y2007C121)
关键词 食管肿瘤 放化疗 病理反应 KI-67 增殖 Esophageal neoplasms Radiochemotherapy Pathology response Ki-67 Proliferation
  • 相关文献

参考文献5

二级参考文献29

  • 1项炜,朱贤立,赵洪洋.导入野生型p53基因对人胶质瘤细胞生长及放疗敏感性的影响[J].中华实验外科杂志,2004,21(10):1244-1245. 被引量:11
  • 2Jun-XingHuang,WeiYan,Zheng-XiangSong,Rong-YuQian,PingChen,EevaSalminen,JormaToppari.Relationship between proliferative activity of cancer cells and clinicopathological factors in patients with esophageal squamous cell carcinoma[J].World Journal of Gastroenterology,2005,11(19):2956-2959. 被引量:8
  • 3黄国俊 汪良骏 等.食管癌外科治疗的远期结果[J].中华外科杂志,1987,25:449-449.
  • 4刘韵源.状态风险分析及其在生物医学中的应用,第1版[M].北京:科学技术出版社,1990.83-98.
  • 5Brenner B, Ilson DH, Minsky BD. Treatment of localized esophageal cancer. Semin Oncol,2004,31:554-565.
  • 6Cao XF, He XT, Ji L, et al. Effects of neoadjuvant radiochemotherapy on pathological staging and prognosis for locally advanced esophageal squamous cell carcinoma. Dis Esophagus 2008,18:527-529.
  • 7Triboulet JP, Mariette C. Esophageal squamous cell carcinoma stage Ⅲ :state of surgery after radiochemotherapy. Cancer Radiother, 2006, 10:456-461.
  • 8Hermann RM, Horstmann O, Hailer F, et al. Histomorphological tumor regression grading of esophageal carcinoma after neoadjuvant radiochemotherapy : which score to use? Dis Esophagus,2006,5 : 329 -334.
  • 9Reynolds JV, Muldoon C, Hollywood D, et al. Long-term outcomes following neoadjuvant chemoradiotherapy for esophageal cancer. Ann Surg,2007 ,245 :707-716.
  • 10Schneider S, Uchida K, Brabender J, et al. Downregulation of TS, DPD,ERCC1, GST-Pi, EGFR, and HER2 gene expression after neoadjuvant three-modality treatment in patients with esophageal cancer. J Am Coil Surg,2005 ,3 :336-344.

共引文献168

同被引文献19

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1365
  • 2赵菊梅,刘涛,田聆,梁传余.热休克蛋白90β在鼻咽癌组织中的表达及与预后的关系[J].现代预防医学,2005,32(7):714-716. 被引量:5
  • 3张阳,张联,潘凯枫,游伟程,李吉友.山东省胃癌高发区人群胃黏膜肠化的预后与标记物表达[J].世界华人消化杂志,2006,14(23):2306-2310. 被引量:2
  • 4Song Y X, Zhou X, Wang Z N, et al. The association be- tween individual SNPs or haplotypes of matrix metallopro- teinase 1 and gastric cancer susceptibility, progression and prognosis [ J ]. PLoS One, 2012, 7 (5) : e38002.
  • 5Hede K. Gastric cancer: trastuzumab trial results spur search for other targets[ J]. J Nail Cancer Inst, 2009, 101 (19) : 1306-1307.
  • 6Sim J D, McCready J, Jay D G. Extracellular heat shock protein (Hsp)70 and Hsp90et assist in matrix metallopro- teinase-2 activation and breast cancer cell migration and invasion [ J ]. PLoS One, 2011, 6 (4) : e 18848.
  • 7Song X, Wang X, Zhuo W, et al. The regulatory mecha- nism of extracellularA Hsp90 { alpha} on matrix metallo- proteinase-2 processing and tumor angiogenesis[ J]. J Biol Chem, 2010, 285 (51 ) :40039-40049.
  • 8Haendeler J, Hoffmann J, Rahman S, et al. Regulation of telomerase activity and anti-apoptotic function by pro- tein interaction and phosphorylation [ J ]. FEBS Lett, 2003, 536 ( 1-3 ) : 180-186.
  • 9Watson R W, Lebret T, Fitxpatrck J M. Heat shock pro- teins in the genitourinary system [J]. CUlT Urol Rep, 2003, 4( 1 ) :70-76.
  • 10Li C F, Huang W W, Wu J M, et al. Heat shock pro- tein 90 overexpression independently predicts inferior dis- ease-free survival with differential expression of the alpha and beta isoforms in gastroimestinal stromal tumors [J]. Clin Cancer Res, 2008, 14(23) :7822-7831.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部